Document Detail


The Role of Cytokines in Atopic Asthma.
MedLine Citation:
PMID:  21428894     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Atopic asthma results from airway inflammation triggered by an environmental allergen. Symptoms include wheezing, dyspnea and cough, airway narrowing and/or hyperresponsiveness to several inhaled stimuli. Inflammation develops in a two-phase fashion. The first phase after exposure to the allergen consists of degranulation and release of both histamine and other stored preformed inflammatory mediators as well as newly synthesized ones, including cytokines, all of which increase mucus secretion and smooth muscle contraction. The second phase occurs later and lasts longer; it is due to different molecules: several cytokines and chemokines, arachidonic acid derivatives, enzymes such as metalloproteinases and cell adhesion molecules. Cytokines are key players in the chronic inflammation in asthma patients, but details on their role and interactions still remain undetermined. Recent evidence suggests that allergic asthma is a multifaceted condition actively controlled by effector as well as regulatory T cells (Tregs). T helper (Th) 2 cells and Th17 cells increase airway inflammation, while Tregs are anti- inflammatory. Cytokines are involved in the development and activation of all T cell subpopulations. They are also involved directly or indirectly in most approaches to asthma treatment. Several cytokines have been tested as therapeutic targets and some of the currently used therapies like corticosteroids, beta agonists and allergen immunotherapy affect cytokine production. The increased knowledge on cytokine interplay and lymphocyte subsets should generate new therapeutic strategies in the near future.
Authors:
M Finiasz; C Otero; L Bezrodnik; S Fin
Related Documents :
15531104 - Upregulation of osteopontin in schwann cells of the sciatic nerves of lewis rats with e...
12797954 - Diverse targets for intervention during inflammatory and neurodegenerative phases of mu...
21282014 - Do low testosterone levels contribute to the pathogenesis of asthma?
19765854 - Cannabinoids and experimental models of multiple sclerosis.
20711704 - The role of complement in amd.
25348514 - Galectin-1 and immune suppression during radiation therapy.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-24
Journal Detail:
Title:  Current medicinal chemistry     Volume:  -     ISSN:  1875-533X     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9440157     Medline TA:  Curr Med Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Immunology Department, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Pacheco de Melo 3081, C1425 AUM, Buenos Aires, Argentina. sfink@hematologia.anm.edu.ar.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quinoline as a Privileged Scaffold in Cancer Drug Discover.
Next Document:  Hybrid Molecules Incorporating Natural Products: Applications in Cancer Therapy, Neurodegenerative D...